Logo image
Feasibility and Satisfaction of Using NET VITALS Self-assessment Tool among Patients with Neuroendocrine Tumors
Journal article   Peer reviewed

Feasibility and Satisfaction of Using NET VITALS Self-assessment Tool among Patients with Neuroendocrine Tumors

Daneng Li, Giovanna J. Imbesi, Lisa Yen, Heeyoung Kim, Can-Lan Sun, Christiana J. Crook, Richard Ballena, Ya-Han Zhang, Rebecca Allen, Mina Sedrak, …
Pancreas, Vol.51(4)
2022

Abstract

Cross-Sectional Studies Feasibility Studies Humans Middle Aged Neuroendocrine Tumors Patient Satisfaction Personal Satisfaction Self-Assessment adult aged Article attitude to health cancer therapy clinical feature cross-sectional study disease assessment feasibility study female gastrointestinal tumor health survey human liver major clinical study male medical information metastasis neuroendocrine tumor neuroendocrine tumor vitals patient satisfaction self concept self evaluation feasibility study middle aged neuroendocrine tumor pathology patient satisfaction satisfaction self evaluation
Objectives There is a lack of effective patient education regarding diagnosis/treatment of neuroendocrine tumors (NETs), possibly related to their rare incidence. Methods In this cross-sectional survey study, NET patients attending the 2019 Annual Los Angeles NET Education Conference were approached to complete NET VITALS, a self-assessment tool gauging patients' perception/awareness of their NET diagnosis/treatment, and a satisfaction survey. Feasibility of NET VITALS, patient satisfaction with NET VITALS, and patients' perception/awareness of their NET diagnosis/treatment were evaluated. Results This analysis included 68 patients (median age, 63 years; 47.1% gastrointestinal NETs; 88.2% metastatic disease). Participation was 88.3% (68/77), with a median of 85.7% of items completed (range, 61.9%-100.0%). More than 30% of the patients answered "Don't know/Not familiar"/left blank questions related to tumor characteristics, years of symptoms, and liver-directed therapies. In addition, 69.5% of the patients did not feel sufficient information about NETs was provided at diagnosis. Overall, 67.8% of the patients felt that NET VITALS provides topics to discuss with providers and 76.3% would recommend NET VITALS to others. Conclusions NET VITALS is a feasible and acceptable self-assessment tool to potentially help patients improve communication about their NET diagnosis/treatment with their physician. Further studies will examine NET VITALS' generalizability and discuss its incorporation into clinical care. © 2022 Wolters Kluwer Health, Inc.

Details

Logo image